Listar por autor "Carreira, Patricia"

Mostrando ítems 1-6 de 6

    • Cardiovascular disease in immune-mediated inflammatory diseases: a cross-sectional analysis of 6 cohorts 

      Fernández-Gutiérrez, Benjamín; Perrotti, Pedro P.; Gisbert, Javier P.; Doménech, Eugeni; Fernández-Nebro, Antonio; Cañete, Juan D.; Ferrándiz, Carlos; Tornero, Jesús; García-Sánchez, Valle; Panés, Julián; Fonseca, Eduardo; Blanco García, Francisco J; Rodríguez-Moreno, Jesús; Carreira, Patricia; Juliá, Antonio; Marsal, Sara; Rodríguez-Rodríguez, Luis (Wolters Kluwer, 2017-06)
      [Abstract] To analyze in several immune-mediated inflammatory diseases (IMIDs) the influence of demographic and clinical-related variables on the prevalence of cardiovascular disease (CVD), and compare their standardized ...

    • Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept 

      Ferreiro-Iglesias, Aida; Montes, Ariana; Pérez-Pampin, Eva; Cañete, Juan D.; Raya, Enrique; Magro-Checa, César; Vasilopoulos, Yiannis; Cáliz, Rafael; Ferrer, Miguel Ángel; Joven, Beatriz; Carreira, Patricia; Balsa, Alejandro; Pascual-Salcedo, Dora; Blanco García, Francisco J; Moreno-Ramos, Manuel J.; Manrique-Arija, Sara; Ordoñez, María del Carmen; Alegre-Sancho, Juan J.; Narváez, Javier; Navarro-Sarabia, Federico; Moreira, Viriginia; Valor, Lara; García-Portales, Rosa; Márquez, Ana; Gómez-Reino, Juan J.; Martín, Javier; González, Antonio (PLoS, 2019-02-28)
      [Abstract] Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that could enable personalized treatments. The genetic biomarkers associated with the response to TNF inhibitors (TNFi) ...

    • GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 

      López-Isac, Elena; Acosta-Herrera, Marialbert; Kerick, Martin; Assassi, Shervin; Satpathy, Ansuman T.; Granja, Jeffrey; Mumbach, Maxwell R.; Beretta, Lorenzo; Simeón, Carmen P.; Carreira, Patricia; Ortego-Centeno, Norberto; Castellvi, Iván; Bossini-Castillo, Lara; Carmona, F. David; Orozco, Gisela; Hunzelmann, Nicolas; Distler, Jörg H.W.; Franke, Andre; Lunardi, Claudio; Moroncini, Gianluca; Gabrielli, Armando; Vries-Bouwstra, Jeska de; Wijmenga, Cisca; Koeleman, Bobby P.C.; Nordin, Annika; Padyukov, Leonid; Hoffmann-Vold, Anna-Maria; Lie, Benedicte; Proudman, Susanna; Stevens, Wendy; Nikpour, Mandana; Vyse, Timothy; Herrick, Ariane L.; Worthington, Jane; Denton, Christopher P.; Allarone, Yannick; Brown, Matthew A.; Radstake, Timothy R.D.J.; Fonseca, Carmen; Chang, Howard Y.; Mayes, Maureen D.; Martín, Javier (Nature, 2019-10-31)
      [Abstract] Systemic sclerosis (SSc) is an autoimmune disease that shows one of the highest mortality rates among rheumatic diseases. We perform a large genome-wide association study (GWAS), and meta-analysis with previous ...

    • Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus 

      Alonso-Pérez, Elisa; Suárez-Gestal, Marian; Calaza, Manuel; Blanco García, Francisco J; Suárez, Ana; Santos, María José; Papasteriades, Chryssa; Carreira, Patricia; Pullmann, Rudolf; Ordi-Ros, Josep; Marchini, Maurizio; Skopouli, Fotini N.; Bijl, Marc; Barrizone, Nadia; Sebastiani, Gian Domenico; Migliaresi, Sergio; Witte, Torsten; Lauwerys, Bernard R.; Kovacs, Attila; Ruzickova, Sarka; Gómez-Reino, Juan J.; González, Antonio (BioMed Central, 2014-06-19)
      [Abstract] INTRODUCTION: We aimed to replicate a recent study which showed higher genetic risk load at 15 loci in men than in women with systemic lupus erythematosus (SLE). This difference was very significant, and it was ...

    • Rheumatoid arthritis response to treatment across IgG1 allotype – anti-TNF incompatibility: a case-only study 

      Montes, Adriana; Pérez-Pampin, Eva; Navarro-Sarabia, Federico; Moreira, Virginia; Rodríguez de la Serna, Arturo; Magallanes, Berta; Vasilopoulos, Yiannis; Sarafidou, Theologia; Fernández.Nebro, Antonio; Ordóñez, María del Carmen; Narváez, Javier; Cañete, Juan D.; Márquez, Ana; Pascual-Salcedo, Dora; Joven, Beatriz; Carreira, Patricia; Moreno-Ramos, Manuel J.; Cáliz, Rafael; Ferrer, Miguel Ángel; García-Portales, Rosa; Blanco García, Francisco J; Magro, César; Raya, Enrique; Valor, Lara; Alegre-Sancho, Juan J.; Balsa, Alejandro; Martín, Javier; Plant, Darren; Isaacs, John; Morgan, Ann W.; Barton, Anne; Wilson, Anthony G. (BioMed Central, 2015-03-18)
      [Abstract] INTRODUCTION: We have hypothesized that incompatibility between the G1m genotype of the patient and the G1m1 and G1m17 allotypes carried by infliximab (INX) and adalimumab (ADM) could decrease the efficacy of ...

    • Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis 

      López-Rodríguez, Rosario; Pérez-Pampin, Eva; Márquez, Ana; Blanco García, Francisco J; Joven, Beatriz; Carreira, Patricia; Ferrer, Miguel Ángel; Cáliz, Rafael; Valor, Lara; Narváez, Javier; Cañete, Juan D.; Ordóñez, María del Carmen; Manrique-Arija, Sara; Vasilopoulos, Yiannis; Balsa, Alejandro; Pascual-Salcedo, Dora; Moreno-Ramos, Manuel J.; Alegre-Sancho, Juan José; Navarro-Sarabia, Federico; Moreira, Virginia; García-Portales, Rosa; Raya, Enrique; Magro-Checa, Rosa; Martín, Javier; Gómez-Reino, Juan J.; González, Antonio (PLoS, 2018-05-07)
      [Abstract] Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. ...